Novartis

Director

• Own the global Microsoft 365 strategy, roadmap, and architectural direction—spanning Exchange, SharePoint, Teams, OneDrive, Power Platform, Viva, Copilot, and related services.
• Champion productivity transformation by identifying, piloting, and scaling emerging capabilities (e.g., AI, automation, next‑gen collaboration).
• Provide end-to-end accountability for service quality, performance, resilience, and support—covering L2–L4 operations via internal teams and strategic suppliers.
• Oversee service health, incident/problem/change management, service request governance, release cycles, and communication processes.
• Ensure adherence to enterprise security, compliance, audit, SOX, and risk management standards.
• Lead Microsoft licensing strategy (EAs, SCEs, add-ons, Copilot licensing, usage telemetry), ensuring cost optimization and entitlement accuracy.
• Act as the single point of accountability for all licensing audits, reporting, and renewals.
• Drive commercial planning, consumption forecasting, and financial stewardship for the entire Microsoft portfolio.
• Lead enterprise-wide rollout, adoption, and value measurement of Microsoft Copilot and AI capabilities.
• Drive AI governance, data readiness, safe-use frameworks, and business integration.
• Drive adoption initiatives—roadshows, blogs, enablement videos, learning experiences—to help employees unlock full M365 value.
• Build an effective change management and communication engine to support continuous platform enhancements.
• Lead a global team of platform architects, service owners, engineers, and operations specialists.
• Build strong partnerships with Digital Workplace, Network, Security, Compliance, TechOps, and business stakeholders.

Director – Productivity, M365 Platforms, Infrastructure Services

Operations

• Support the Operations Process Automation Program in Quality by driving end-to-end process mapping and documentation
• Enable process excellence by ensuring accurate, standardized and high-quality supporting process mapping across Quality
• Prepare executive-ready presentations, reports, and dashboards for leadership
• Build and maintain strong working relationships with the Global Process Owners (GPOs) within Quality

Quality Operations Process Specialist

Business Analyst

• Ensure traceability between user requirements, functional specifications, and testing deliverables.
• Support validation and testing while maintaining compliance with security and regulatory standards.
• Collaborate with AQS business and IT teams to design and deliver modern technology solutions.
• Coordinate integration touchpoints and ensure accurate data flow across SCAPE SCE interfaces.
• Maintain SCAPE product backlog and align user requirements across project workstreams.
• Partner with vendors to interpret and implement user requirements effectively.
• Drive user experience considerations and adherence to compliance in solution design and deployment.

Associate Director, Clinical Enablement, IT Business Analyst

• Serve as the primary strategic thought and sparring partner to several U.S. cross‑functional launch teams
• Shape end‑to‑end launch strategy across the full planning horizon
• Challenge and elevate brand teams’ thinking on waves of growth and strategic choices
• Ensure launch strategies reflect the available evidence, patient impact, and long-term value creation
• Ensure launch plans integrate functional deliverables into a singular, cohesive plan
• Drive data-informed strategic decision-making and inform annual and multi-year financial planning
• Lead high‑impact, multifunctional initiatives to evolve Novartis’ launch excellence method
• Capture and scale best practices in strategic launch planning

Director – Launch Excellence Strategy

Pricing Analyst

• Develops portfolio contract strategies in line with Business Unit sales goals and customer needs; aligns strategy with other key Sales, Marketing, Medical and Market Access functions and ensures cross-functional support
• Develops pricing, contracting and channel strategies for optimal patient access and profitability for assigned new and in-line products focusing on the full commercialization continuum
• Responsible for the strategic and financial evaluation of potential contracting efforts, support of customer negotiations and end-to end Brand payer contract execution
• Support the development of market access strategies for inline and pipeline products by conducting pre-modelling scenarios for market and competitor analyses, stakeholder and pricing and channel research.
• Comply with all relevant laws and regulations and Novartis policies, and procedures, and ensure others around him/her do the same.

Director, Channel & Pricing Strategy – Advanced Platforms

• Translate Novartis Patient Support program requirements into effective NPS field associate customer engagements models
• Lead the development and communication of field strategy, engagement and tactical plans
• Co-own the annual NPS field business planning cycle
• Design and execute clear and effective external stakeholder communications
• Collect, translate, and communicate field insights to inform NPS and IPST strategies

Director, NPS Field Engagement Strategy

Financial Planning and Analysis

• Act as a trusted finance partner on Deal Teams, supporting BD Directors and country BD leads across APMA on BD&L transactions including EPDA, licensing, divestments, co‑promotion, and strategic initiatives.
• Provide independent, high‑quality financial guidance and propose optimal deal structures and terms that enhance value and minimize risk for Novartis.
• Lead financial modelling for transactions, rapidly assessing deal economics, identifying key value drivers, and evaluating sensitivities.
• Prepare P&Ls and financial support documents for APMA/Cluster DRC business cases with accuracy and clarity.
• Coordinate with key finance stakeholders (CFO, FRA, Tax, Funds Flow) to gather inputs and integrate feedback into term sheets and contracts, proactively highlighting financial issues to negotiation leads.
• Challenge deal terms that fall short of internal benchmarks or introduce undue risk, ensuring alignment with Novartis standards.
• Provide financial insights to shape portfolio prioritization and support short-, mid-, and long‑term partnering strategy decisions.
• Oversee financial performance of existing deals, including reporting, tracking, and escalating deviations from agreed parameters.
• Maintain integrity and timely updates of APMA finance dashboard data while supporting BD Directors with portfolio assessments, capability building, and identification of new BD opportunities.

Group Head – BD&L Finance, APMA

Auditor

• In this role you will lead, support and report independent GMP audits according to the Novartis Quality System and the current GMP regulations to assess compliance with applicable regulations, standards, and guidance documents.
• Review and approve corrective action plans in support of the audit observations.
• The audits performed include internal and external targets of manufacturing sites, development centers, quality systems, contract manufacturers, laboratories, warehouses, country organizations, and suppliers.
• Ensure alignment with strategic direction of the company and assist in driving implementation of the applicable actions and provides consultation to Novartis business units through risk based assessments.
• Travel up to 60% of time.
• Support the strategic development of an effective global risk-based audit strategy and program.
• Collect, collate, and incorporate input into the audit strategy and plan.
• Plan, lead, conduct, document, and follow-up of GMP audit according to the requirements specified in the respective Novartis Quality procedures as well as applicable regulations, standards, quality agreements, and guidance documents.
• Provide technical guidance, mentoring, and training on audit activities.
• Provide regulatory guidance for timely remediation and recommendations regarding acceptability of the proposed filing.
• Prepare audit reports according to NVS requirements and timelines.
• Identify and report best practices and lessons learned to support development/training of GMP auditors.
• Mentor junior GMP staff as required.

Global Senior Quality Auditor

Security Engineer

• Oversee AI architectural activities for a specific business or technology domain, or architectural practice area, and manage the development of solution architectures for projects or programs within a business area.
• Define AI security standards and direction of architecture in the specific business or technical domain, and establish best practices for protecting AI pipelines, datasets, and models.
• Define and develop the logical architectural design and strategies necessary to secure the Organizations’ AI domain / infrastructure
• Utilize architecture patterns to suggest the most adequate utilization of technical platforms in support of the holistic AI solution security architecture design.
• Define, create and evolve the Architecture Governance Framework (e.g. architecture methods, practices and standards ) for AI.
• Understand and advocate the principles of business and IT strategies, Be prepared to sell the Architecture process, its outcome and ongoing results, and to lead the communication, marketing or educational activities needed to ensure Enterprise Architecture success and use.
• Assess the organization's AI landscape and identifying potential vulnerabilities or weaknesses including identification and evaluation of risks associated with training, deployment, and operation of AI models; keep up-to-date with the latest security threats, trends, and best practices to ensure the AI security infrastructure remains effective, and evaluate and select security tools, technologies, and products to enhance AI security.
• Collaborate with IT teams to integrate security measures into all aspects of the AI platforms and LLMs related processes, working with data scientists, engineers, and DevOps teams to embed security into the AI development lifecycle, and provide guidance and support to other Engineering teams in implementing security measures and resolving security-related issues
• Regularly reporting on the status of AI security measures to senior management and stakeholders.
• Securing AI systems from development through deployment, including securing training data and monitoring deployed models for threats.
• Knowledge of AI solutions development lifecycle and environments including MLOps and related tooling (e.g. model repositories, data pipelines, deployment architectures).

AI Enterprise Security Architect

• Shape and articulate a bold, future-focused vision for field capabilities
• Design and evolve a scalable, adaptable capability framework
• Partner across commercial, brand, medical, and field teams
• Translate organizational needs and market dynamics into clear, actionable capability recommendations
• Champion innovative approaches to capability building
• Identify and validate future skills through pilots, benchmarking, and continuous scanning
• Develop and maintain a clear capability roadmap
• Define practical tools, resources, and frameworks
• Establish meaningful metrics and feedback loops to assess capability adoption
• Use insights from performance and adoption data to continuously refine capability strategy

Director, Future Field Engagement Strategy – Capabilities

• Architect and lead future‐ready measurement frameworks
• Translate complex, aggregated performance signals into clear, strategic measurement constructs
• Shape balanced scorecards that intentionally measure both outcomes and critical enterprise behaviors
• Serve as a strategic advisor to senior leadership by delivering forward‐looking insights
• Reimagine incentive compensation strategies to align with evolving field roles
• Steward incentive frameworks in partnership with Incentive Compensation teams

Director, Future Field Engagement Strategy – Metrics & Incentives

• Provide Clinical Science leadership for an assigned therapeutic area; partner with Medical Director/MST Lead to co-develop program strategy, evidence generation plans, and study concepts aligned to portfolio priorities.
• Serve as Clinical Science lead on the MST and represent US Medical Affairs in key cross-functional forums and workstreams.
• Lead scientific review, prioritization, and oversight of Investigator Initiated Trials (IITs) in partnership with Medical Affairs and governance stakeholders.
• Lead and support external research collaborations (e.g., academic partnerships, consortium-based studies) from concept through execution, ensuring scientific quality and operational rigor.
• Ensure consistent clinical science standards, governance, and best practices across IITs and external collaborations.
• Drive Medical Office clinical trial acceleration across USMA to reduce cycle times and improve study start-up and execution.
• Coordinate trial acceleration activities across Clinical Sciences, Medical Affairs, and cross-functional partners; establish clear milestones, owners, and accountability.
• Identify, prioritize, and execute acceleration initiatives; translate strategic objectives into measurable operational impact (timelines, throughput, quality).
• Act as an integrator across enabling functions (e.g., medical leadership, field medical, governance, contracts) to implement scalable acceleration ways of working.
• Lead evidence generation acceleration initiatives (e.g., portfolio control tower approach, acceleration playbooks, external collaboration strategy).
• Track, communicate, and continuously improve outcomes using data-driven insights, dashboards, and performance metrics.
• Provide scientific and operational oversight for assigned studies/programs, including feasibility input and contributions to protocols and key study documents.
• Oversee vendor, budget, and resource planning as applicable; ensure accurate forecasting and delivery against commitments.
• Lead, coach, and develop a team of trial leads and/or matrixed resources; support hiring, retention, and capability building.
• Ensure compliance with SOPs, GCP, and ethical requirements; contribute to continuous improvement of processes and working practices.

Director, Clinical Sciences – Therapeutic Lead

• Architect and lead the development of next‑generation customer engagement methodology
• Draw on leading customer engagement practices across industries
• Define and continuously optimize customer planning processes
• Design scalable, adaptable engagement frameworks
• Establish clear, practical frameworks for multi‑channel and cross‑functional engagement
• Partner closely with Insights & Analytics to ensure engagement models are grounded in customer, market, and performance insights
• Lead the evolution of field deployment strategies
• Create agile feedback loops with field teams and stakeholders

Director – Future Field Engagement Strategy

• Serve as a strategic partner to the US Chief Data Officer.
• Lead high-impact initiatives that accelerate data-driven transformation.
• Design and execute programs that elevate organizational capabilities in AI and data literacy.
• Drive launch excellence and deliver on other strategic priorities within the Data Strategy & Governance function.
• Partner with vendors and stakeholders to scale and deliver training and cultural programs across the US Commercial organization.
• Measure program effectiveness through adoption metrics, competency assessments, and business impact.

Director of Data Solutions

Manager

• Once an opportunity has been identified and triage is completed by S&E (Search & Evaluation), the Senior Manager M&A Transactions will outline a deal strategy (game plan), including a timeline to signing, governance planning, gating diligence items, bidding strategy, and an engagement plan with the target company.
• Shape and secure non-binding offer and ultimately binding offer terms in collaboration with M&A Finance, DD (Due Diligence), M&A Legal, M&A Tax, and other relevant line functions within Biomedical Research (BR), Development, TAS, US and International as needed.
• Build and manage high-performing teams on a deal-by-deal basis, ensuring appropriate level of seniority and cross-functional representation to enable consistently high-quality decision-making at the Executive Committee Novartis (ECN) and Board of Directors (BoD) level.
• In collaboration with DD head, launch and govern a VDR (Virtual Data Room) based diligence, ensuring target company is disclosing all relevant information and Novartis internal experts are reviewing all relevant information.
• Coordinate relevant business case inputs and ensure appropriate review from relevant TAL (Therapy Area Leadership) members and ECN members.
• Incorporate findings from diligence into the risk and value assessment and solicit support from third parties in the diligence process as needed to inform the assessment and recommendation.
• Primary counterpart to M&A legal to solicit business input on transaction documents.
• Prepare decision-making framework for ECN DC and BoD, ensuring consistent approach to risk and value assessment of an opportunity.
• Ensure all new information is adequately reviewed by relevant line functions with escalation to C&BD management and relevant ECN members as appropriate.
• Key partner to integration function post-signing to ensure knowledge transfer and strategic value drivers of the deal are prioritized in the integration planning process.